2.0
3 Jul 2024
Former employee, more than 1 year
Washington, DC
Recommend
CEO approval
Business outlook
Pros
You'll learn about the generics and biosimilars industries
Cons
Dysfunctional environment. Association members do not get along, making it difficult to align on messaging. The industry players have very little money to spend on communications campaigns. The AAM executive team is not supportive of communications - only focused on lobbying and regulating.